XML 69 R38.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2024

Schedule of percentages of deferred revenue by year


		Revenue
Year:		Recognition
2025		90	%
2026		9	%
2027		1	%
Total		100	%

Schedule of revenue generated in geographic regions for years indicated

The following geographic data includes revenue generated from the Company’s third-party distributors. The Company’s revenue was generated in the following geographic regions and by product line for the periods indicated (in thousands):


		Revenues by Geography
		Year ended December 31,
		2024					2023
					% of					% of
		Amount			Revenues		Amount			Revenues

		(in thousands, except percentages)
U.S.		$	72,488		97	%	$	69,336		97	%
International			2,402		3	%		2,012		3	%
Total revenues		$	74,890		100	%	$	71,348		100	%


		Revenues by Geography
		Year ended December 31,
		2023					2022
					% of					% of
		Amount			Revenues		Amount			Revenues

		(in thousands, except percentages)
United States		$	69,336		97	%	$	63,406		97	%
International			2,012		3	%		1,800		3	%
Total revenues		$	71,348		100	%	$	65,206		100	%

Schedule of revenue generated in product category for years indicated


		U.S. Revenues by Product Category
		Year ended December 31,
		2023					2022
					% of					% of
		Amount			Revenues		Amount			Revenues

		(in thousands, except percentages)
NeuroStar Advanced Therapy System		$	16,460		24	%	$	16,575		26	%
Treatment sessions			50,896		73	%		45,077		71	%
Other			1,980		3	%		1,754		3	%
Total U.S. revenues		$	69,336		100	%	$	63,406		100	%

Schedule of revenue generated in product category for years indicated


		International Revenues by Product Category
		Year ended December 31,
		2024					2023
					% of					% of
		Amount			Revenues		Amount			Revenues

		(in thousands, except percentages)
NeuroStar Advanced Therapy System		$	826		34	%	$	629		31	%
Treatment sessions			613		26	%		754		38	%
Other			963		40	%		629		31	%
Total International revenues		$	2,402		100	%	$	2,012		100	%


		International Revenues by Product Category
		Year ended December 31,
		2023					2022
					% of					% of
		Amount			Revenues		Amount			Revenues

		(in thousands, except percentages)
NeuroStar Advanced Therapy System		$	629		31	%	$	811		45	%
Treatment sessions			754		38	%		354		20	%
Other			629		31	%		635		35	%
Total International revenues		$	2,012		100	%	$	1,800		100	%